Equities

Alliance Pharma PLC

APH:LSE

Alliance Pharma PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)34.95
  • Today's Change0.05 / 0.14%
  • Shares traded330.99k
  • 1 Year change-41.56%
  • Beta0.8320
Data delayed at least 20 minutes, as of Apr 26 2024 17:46 BST.
More ▼

Profile data is unavailable for this security.

About the company

Alliance Pharma plc is a United Kingdom-based consumer healthcare company. The principal activity of the Company is to act as a holding company. The principal activity of the Company is the acquisition, marketing and distribution of consumer healthcare and pharmaceutical products. The Company's segments are strategic business units that represent different parts of the overall product portfolio, these being Consumer Healthcare brands and Prescription Medicines. Its Consumer Healthcare brands include Kelo-Cote franchise, Amberen, Nizoral, MacuShield, Aloclair, Vamousse, and other consumer healthcare brands. Its Prescription Medicines include Hydromol, Flamma Franchise, Forceval and other prescription medicines. Its products include Aloclair Plus Gel, Changmin, Fazol Cream, Hydromol Ointment, Kelo-Stretch Cream, and others. It holds the marketing rights to around 80 Consumer Healthcare brands and Prescription Medicines, which are sold around the world in more than 100 countries.

  • Revenue in GBP (TTM)170.05m
  • Net income in GBP-7.06m
  • Incorporated2001
  • Employees249.00
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Futura Medical PLC3.10m-6.51m106.86m12.00106.86m12.00
Animalcare Group Plc74.35m1.20m130.43m220.00130.43m220.00
Creo Medical Group PLC29.23m-25.10m131.04m279.00131.04m279.00
Allergy Therapeutics plc53.26m-50.22m135.84m635.00135.84m635.00
4Basebio PLC354.00k-6.28m137.02m--137.02m--
Avacta Group Plc16.03m-42.08m175.21m120.00175.21m120.00
Alliance Pharma plc170.05m-7.06m188.87m249.00188.87m249.00
hVIVO PLC56.04m16.12m192.21m274.00192.21m274.00
Oxford BioMedica plc119.02m-61.63m228.50m891.00228.50m891.00
Bioventix PLC13.60m8.67m232.27m16.00232.27m16.00
Niox Group PLC36.80m9.50m281.55m85.00281.55m85.00
Data as of Apr 26 2024. Currency figures normalised to Alliance Pharma PLC's reporting currency: UK Pound GBX

Institutional shareholders

50.90%Per cent of shares held by top holders
HolderShares% Held
Van Lanschot Kempen Investment Management NV (United Kingdom)as of 06 Nov 202355.16m10.21%
Slater Investments Ltd.as of 21 Sep 202354.12m10.02%
Van Lanschot Kempen Investment Management NVas of 17 Mar 202345.63m8.45%
Rathbones Investment Management Ltd.as of 06 Oct 202325.97m4.81%
Fidelity Management & Research Co. LLCas of 17 Mar 202319.64m3.64%
Investec Wealth & Investment Ltd.as of 17 Mar 202317.26m3.20%
Artemis Investment Management LLPas of 29 Dec 202316.15m2.99%
RBC Global Asset Management (UK) Ltd.as of 25 Aug 202314.55m2.69%
Rowan Dartington & Co. Ltd. (Broker)as of 02 Dec 202314.44m2.67%
Brooks Macdonald Asset Management Ltd.as of 02 Dec 202312.14m2.25%
More ▼
Data from 29 Sep 2023 - 02 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.